(Q39158684)

9 September 2017

title

The current treatment landscape: the need for antifungal stewardship programmes (English)

1 reference

9 September 2017

Emilio Bouza

2

0 references

Patricia Muñoz

series ordinal

1

object named as

Patricia Muñoz

1 reference

9 September 2017

author name string

COMIC (Collaboration Group on Mycosis) study group

series ordinal

3

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 November 2016

1 reference

Journal of Antimicrobial Chemotherapy

9 September 2017

published in

1 reference

9 September 2017

volume

71

1 reference

9 September 2017

issue

suppl 2

1 reference

9 September 2017

page(s)

ii5-ii12

1 reference

The case for antifungal stewardship

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Antimicrobial stewardship: optimizing antibiotic use in an era of increasing resistance and rising costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Adherence to recommendations for the use of antifungal agents in a tertiary care hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Antifungal management practices in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Poor compliance with antifungal drug use guidelines by transplant physicians: a framework for educational guidelines and an international consensus on patient safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Training should be the first step toward an antifungal stewardship program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

A matched-control evaluation of an antifungal bundle in the intensive care unit at a university teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

An international cross-sectional survey of antimicrobial stewardship programmes in hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Antifungal stewardship in daily practice and health economic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

The role of the multidisciplinary team in antifungal stewardship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Antifungal stewardship in a tertiary-care institution: a bedside intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Understanding the determinants of antimicrobial prescribing within hospitals: the role of "prescribing etiquette"

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

The role of behavior change in antimicrobial stewardship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

How much European prescribing physicians know about invasive fungal infections management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Candida biomarkers in patients with candidaemia and bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Endemic genotypes of Candida albicans causing fungemia are frequent in the hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Is azole resistance in Aspergillus fumigatus a problem in Spain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Environmental surveillance and other control measures in the prevention of nosocomial fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW391

21 January 2018

Identifiers

DOI

10.1093/JAC/DKW391

1 reference

9 September 2017

1 reference